Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/23/2025

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

NPH Insulin Dosing

  • The American Diabetes Association recommends morning administration of NPH insulin to counteract steroid-induced hyperglycemia, matching the pharmacokinetic profile of glucocorticoids, which peak in 4-8 hours 1
  • Initial NPH insulin dosing should be 0.3-0.4 units/kg for patients on high-dose glucocorticoids, according to the American Association of Clinical Endocrinologists 2
  • The NPH should be administered in the morning to coincide with the peak action of methylprednisolone, as suggested by the Endocrine Society 2
  • Consider continuing the patient's basal insulin coverage while adding NPH to specifically address the steroid effect, as recommended by the American Diabetes Association 3

Carbohydrate Ratio

  • For patients on high-dose steroids, a more aggressive carbohydrate ratio is needed, with a starting point of 1 unit of rapid-acting insulin for every 8-10 grams of carbohydrate, according to the Academy of Nutrition and Dietetics 3
  • This ratio may need adjustment based on blood glucose monitoring results, as suggested by the American Diabetes Association 3
  • For meals with the greatest postprandial glucose excursions, consider a more aggressive ratio of 1:6, as recommended by the Endocrine Society 3

Correction Scale

  • For correction insulin, use the "1800 rule" as a starting point, with a correction factor of approximately 1 unit for every 20-25 mg/dL above target, according to the American Association of Clinical Endocrinologists 3
  • Recommended correction scale:
    • Blood glucose 150-200 mg/dL: 2 units 3
    • Blood glucose 201-250 mg/dL: 4 units 3
    • Blood glucose 251-300 mg/dL: 6 units 3
    • Blood glucose 301-350 mg/dL: 8 units 3
    • Blood glucose >350 mg/dL: 10 units and notify provider 3

Special Considerations for Transplant Patient

  • Monitor blood glucose every 4-6 hours while adjusting therapy to prevent both hyperglycemia and hypoglycemia, as recommended by the American Diabetes Association 3
  • Patients with kidney transplants often have increased insulin resistance due to immunosuppressive medications and steroids, according to the National Kidney Foundation 2
  • If hypoglycemia occurs, determine the cause; if no clear reason is found, lower the corresponding insulin dose by 10-20%, as suggested by the Endocrine Society 3

Monitoring and Adjustment

  • Blood glucose targets should be 100-180 mg/dL for this post-transplant patient, according to the American Diabetes Association 3
  • As the steroid dose is tapered, the NPH insulin dose should be reduced proportionally, typically 10-20% reduction for each significant decrease in steroid dose, as recommended by the American Association of Clinical Endocrinologists 2
  • Assess adequacy of insulin dose at every visit, looking for clinical signals of overbasalization, as suggested by the American Diabetes Association 3

Common Pitfalls to Avoid

  • Failing to match the timing of NPH insulin with steroid administration can lead to inadequate coverage of steroid-induced hyperglycemia, according to the American Diabetes Association 1
  • Failing to reduce insulin doses as steroids are tapered can result in hypoglycemia, as warned by the Endocrine Society 2

Insulin Dose Adjustments for Steroid-Induced Hyperglycemia

Immediate Insulin Regimen Changes

  • Patients on high-dose steroids require 40-60% more prandial insulin than standard dosing due to increased insulin resistance, as recommended by the American Diabetes Association 4
  • Increase NPH from 25 units to 35-40 units given in the morning to match the peak hyperglycemic effect of prednisone, which occurs between midday and midnight, according to the American Association of Clinical Endocrinologists 4

Why This Regimen Works

  • Prednisone causes hyperglycemia predominantly between midday and midnight, with peak effect 4-8 hours after morning administration, as stated by the Endocrine Society 4